TVP23C-CDRT4 is a gene fusion product involved in cellular homeostasis and senescence regulation. While TVP23C itself is annotated to the Golgi apparatus and vesicle-mediated protein transport, the TVP23C-CDRT4 fusion represents a distinct entity with broader functional significance. Mechanism: TVP23C-CDRT4 plays a critical role in regulating mitochondrial reactive oxygen species (ROS) production and cellular senescence 1. Knockdown of TVP23C-CDRT4 reduces mitochondrial ROS generation and restores senescence-associated phenotypes, suggesting the fusion product functions as a negative regulator of mitochondrial oxidative stress 1. The gene exhibits semi-extractability properties consistent with localization to nuclear compartments dissociated from chr17 2. Disease Relevance: TVP23C-CDRT4 is significantly associated with adenoid cystic carcinoma (ACC), where it forms a novel gene fusion detected in ACC tissues and shows high expression levels 3. This fusion may contribute to ACC pathogenesis alongside other genomic alterations. Clinical Significance: The identification of TVP23C-CDRT4 as a target for senescence rejuvenation through ROS modulation opens therapeutic avenues for age-related diseases 1. However, its role in ACC suggests context-dependent functions requiring further investigation.